Skip To Main Content
Anishia-Rawther Karedath on Muck Rack

Anishia-Rawther Karedath

As seen in: JAMA Network
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Anishia-Rawther

Contact Anishia-Rawther, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Skin Toxic Effects and Survival With Enfortumab Vedotin–Pembrolizumab in Advanced Urothelial Carcinoma

|
By Zachariah Thomas, Cindy Jiang, Patrick Speck, Emanuele Crupi, Mohammad Moussa, Adrienne Joseph, Carly F. Stender, Michael Glover, Andrew Johns, Jianjun Gao, Monica Desai, Amishi Y. Shah, Sangeeta Goswami, Arlene Siefker-Radtke, Comron Hassanzadeh, Kelly K. Bree, Ashish M. Kamat, Charles C. Guo, Omar Pacha, Anisha Patel, Jonathan Curry, Alex Sherry, Pavlos Msaouel, Matthew Campbell, Omar Alhalabi, Anishia-Rawther Karedath, Sheeba P. Varughese, Wenhong Ren
| JAMA Network Verified
Skin Toxic Effects and Survival With Enfortumab Vedotin–Pembrolizumab in Advanced Urothelial Carcinoma Supplement 1. eFigure 1. Directed Acyclic Graph for Covariate Selection eFigure 2. Assessment of the Proportional Hazards Assumption Using Scaled Schoenfeld Residuals eTable 1. Skin Toxicity Characteristics and Treatment Modifications eTable 2. Assessment of Proportional Hazards Assumption eTable 3.
Open in Who Shared Issue with article?
See all 1 articles